Publications (492) MANUEL PRAGA TERENTE publications

filter_list

2025

  1. Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy

    Kidney International Reports, Vol. 10, Núm. 2, pp. 432-446

2024

  1. Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathy

    Clinical Kidney Journal, Vol. 17, Núm. 6

  2. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

    Kidney International, Vol. 105, Núm. 1, pp. 177-188

  3. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 8, pp. 1288-1298

  4. Developing Therapies for C3 Glomerulopathy Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group

    Clinical Journal of the American Society of Nephrology, Vol. 19, Núm. 9, pp. 1201-1208

  5. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

    Kidney International, Vol. 105, Núm. 6, pp. 1279-1290

  6. Microscopic hematuria in C3G and IC-MPGN

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 9, pp. 1529-1532

  7. Nefropatías glomerulares primarias.

    Medicina interna (Elsevier España), pp. 894-904

  8. Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

    Kidney International, Vol. 106, Núm. 6, pp. 1038-1050

  9. Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort

    Clinical Kidney Journal, Vol. 17, Núm. 8

  10. Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients from Uncontrolled Donation after Circulatory Death Donors with High Renal Resistive Index

    Transplantation Direct, Vol. 10, Núm. 6, pp. E1649

  11. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

  12. Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy

    Clinical Kidney Journal, Vol. 17, Núm. 9

  13. Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340

  14. Ten tips on immunosuppression in primary membranous nephropathy

    Clinical Kidney Journal, Vol. 17, Núm. 6

  15. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International